Immunization against hepatitis B virus by mucosal administration of antigen-antibody complexes

Viral Immunology

Volumn 11, Issue 4, 1998, Pages 245-252

  McCluskie, Michael J ^a,b   Wen, Yu Mei ^c   Di, Qu ^c   Davis, Heather L ^a,b  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; CHOLERA TOXIN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; ISCOM; OLIGODEOXYNUCLEOTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; FEMALE; HELPER CELL; HEPATITIS B; HEPATITIS B VIRUS; IMMUNE RESPONSE; IMMUNIZATION; INHALATIONAL DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; MOUSE; MUCOSA; NONHUMAN; PARENTERAL DRUG ADMINISTRATION;

EID: 0032410080     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.1998.11.245     Document Type: Article

References (30)

1. Belshe, R.B., P.M. Mendelman, J. Treanor, J. King, W.C. Gruber, P. Piedra, D.I. Bernstein, F.G. Hayden, K. Kotloff, K. Zangwill, D. Iacuzio, and M. Wolff. 1998. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. N. Engl. J. Med. 338:1405-1412.
2. Celis, E., I. Kato, R.W. Miller, and T.W. Chang. 1985. Regulation of the human immune response to HBsAg: effects of antibodies and antigen conformation in the stimulation of helper T cells by HBsAg. Hepatology 5:744-751.
3. Celis, E., V.W. Zurawski, Jr. and T.W. Chang. 1984. Regulation of T-cell function by antibodies: Enhancement of the response of human T-cell clones to hepatitis B surface antigen by antigen-specific monoclonal antibodies. Proc. Natl. Acad. Sci. USA 81:6846-6850.
4. Centres for Disease Control. 1987. Recommendations of the Immunization Practises Advisory Committee. Update on hepatitis B prevention. Morbidity Mortality Weekly Report 36:353.
5. Davis, H.L., R. Weeranta, T.J. Waldschmidt, L. Tygrett, J. Schorr, and A.M. Krieg. 1998. CpG DNa is a potent enhancer of specific immunity in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160:870-876.
6. Deo, Y.M., R.F. Graziano, R. Repp, and J.G. Van de Winkel. 1997. Clinical significance of IgG Fc receptors and Fc gamma R-directed immunotherapies. Immunol. Today 18:127-135.
7. Gallichan, W.S., and K.L. Rosenthal. 1995. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus. Vaccine 13:1589-1595.
8. Gallichan, W.S., and K.L. Rosenthal. 1998. Long-term immunity and protection against herpes simplex virus type 2 in the murine female genital tract after mucosal but not systemic immunization. J. Infect. Dis. 177:1155-1161.
9. Haddad, E.E., C.E. Whitfill, A.P. Avakian, C.A. Ricks, P.D. Andrews, J.A. Thoma, and P.S. Wakenell. 1997. Efficacy of a novel infectious bursal disease virus immune complex vaccine in broiler chickens. Avian Dis. 41:882-889.
10. Halpern, M.D., R.J. Kurlander, and D.S. Pisetsky. 1996. Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha. Cell. Immunol. 167:72-78.
11. Hanke, T., C. Botting, E.A. Green, P.W. Szawlowski, E. Rud, and R.E. Randall. 1994. Expression and purification of nonglycosylated SIV proteins, and their use in induction and detection of SIV-specific immune responses. AIDS Res. Hum. Retrovir. 10:665-674.
12. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 1:1179-1184.
13. Homquist, E., and N. Lycke. 1993. Cholera toxin adjuvant greatly promotes antigen priming of T cells. Eur. J. Immunol. 23:2136-2143.
14. Karron, R.A., P.F. Wright, S.L. Hall, M. Makhene, J. Thompson, B.A. Burns, S. Tollefson, M.C. Steinhoff, M.H. Wilson, D.O. Harris, et al. 1995. A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children. J. Infect. Dis. 171:1107-1114.
15. Karron, R.A., P.F. Wright, J.E. Crowe Jr., M.L. Clements-Mann, J. Thompson, M. Makhene, R., Casey, B.R. Murphy, et al. 1997. Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children. J. Infect. Dis. 176:1428-1436.
16. Klinman, D.M., A.K. Yi, S.L. Beaucage, J. Conover, A.M. Krieg. 1996. CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc. Natl. Acad. Sci. USA 93:2879-2883.
17. McCluskie, M.J., and H.L. Davis. 1998. CpG DNA is a potent enhancer of systemic and mucosal immune responses against hepatitis B surface antigen with intranasal administration to mice. J. Immunol. 161:4463-4466.
18. Moldoveanu, Z., M.L. Clements, S.J. Prince, B.R. Murphy, and J. Mestecky. 1995. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes. Vaccine 13:1006-1012.
19. Munoz, E., A.M. Zubiaga, M. Merrow, N.P. Sauter, and B.T. Huber. 1990. Cholera toxin discriminates between T helper 1 and 2 cells in T cell receptor-mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95-103.
20. Pokric, B., D. Sladic, S. Juros, and S. Cajavec. 1993. Application of the immune complex for immune protection against viral disease. Vaccine 11:655-659.
21. Rappuoli, R., and M. Pizza. 1996. Novel molecular biology approaches to acellular vaccines. Biotechnol. Annu. Rev. 2:391-408.
22. Sanchez-Mejorada, G., and C. Resales. 1998. Signal transduction by immunoglobulin Fc receptors. J. Leukoc. Biol. 63:521-533.
23. Takahashi, I., M. Marinaro, H. Kiyono, R.J. Jackson, I. Nakagawa, K. Fujihashi, S. Hamada, J.D. Clements, K.L. Bost, and J.R. McGhee. 1996. Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin. J. Infect. Dis. 173:627-635.
24. Wen, Y.M., S.Q. Guo, W. Zhang, X.H. Yan, P.Y. Li. 1994. Enhanced immunogenicity in mice with hepatitis B vaccine complexed to human hepatitis B immunoglobulin. Chin. Med. J. (Engl.) 107:741-744.
25. Wen, Y.M., X.H. Wu, D.C. Hu, Q.P. Zhang, and S.Q. Guo. 1995. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet 345:1575-1576.
26. Wen, Y.M., S. Xiong, and W. Zhang. 1994. Solid matrix-antibody-antigen complex can clear viraemia and antigenaemia in persistent duck hepatitis B virus infection. J. Gen. Virol. 75:335-339.
27. Wiedermann, U., B. Jahn-Schmid, R. Fritsch, L. Bauer, H. Renz, D. Kraft, and C. Ebner. 1998. Effects of adjuvants on the immune response to allergens in a murine model of allergen inhalation: cholera toxin induces a Th1-like response to Bet v 1, the major birch pollen allergen. Clin. Exp. Immunol. 111:144-151.
28. World Health Organization. 1996. State of the world's vaccines and immunization. Global Programme for Vaccines and Immunization WHO/GPV/96.04.
29. Yamamoto, S., H. Kiyono, M. Yamamoto, K. Imaoka, K. Fujihashi, F.W. Van Ginkel, M. Noda, Y. Takeda, and J.R. McGhee. 1997. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity. Proc. Natl. Acad. Sci. USA 94:5267-5272.
30. Zhou, S.H., and Y.M. Wen. 1997. Effects of HBsAg-anti-HBs complex on antigen processing, presentation and induction of cytokines. Chin. J. Virol. 13:269-271.